Revvity has announced a comprehensive initiative to expand early detection capabilities for type 1 diabetes, combining in vitro diagnostic assay development with laboratory testing services in collaboration with Sanofi. The programme centres on advancing the company’s existing research-use autoantibody testing platform towards regulatory approval and broader clinical implementation.
Bio-Rad Laboratories has secured exclusive European distribution rights for Gencurix’s CE-IVD Droplex digital PCR oncology testing kits, marking a significant expansion of the companies’ existing collaboration in molecular diagnostics.
SPT Labtech and Agilent Technologies have announced the release of automated target enrichment protocols for the firefly®+ platform, designed to streamline genomic sequencing workflows in clinical research, oncology, and precision medicine applications. The protocols, which integrate Agilent’s SureSelect Max DNA Library Prep Kit with SPT Labtech’s liquid handling automation, are now available to all firefly+ […]
PromoCell GmbH, the Heidelberg-based manufacturer of primary human cells and specialised cell culture media, has announced its entry into the Good Manufacturing Practice (GMP) arena with a new service portfolio designed for cell-based therapy and regenerative medicine applications. The company debuted its Custom GMP Cell Culture Media Services at the 32nd European Society of Gene […]
BioMed X has launched XFem Labs, a dedicated women’s health research and development accelerator at its Heidelberg facility, marking a strategic expansion of the institute’s translational research portfolio. The initiative, backed by a $2 million grant from the Gates Foundation, will focus on addressing critical gaps in women’s healthcare, with particular emphasis on accessible contraceptive […]
University of Illinois researchers have developed oPool+ display, a breakthrough method that enables researchers to construct and test hundreds of antibodies in parallel rather than individually. The platform dramatically reduces costs and time for antibody discovery across multiple diseases, with the aim of transforming therapeutic development for cancer, infectious diseases, and autoimmune conditions.
Italian researchers have demonstrated that immunoblot testing for anti-F-actin antibodies delivers diagnostic accuracy equivalent to established ELISA methods in autoimmune hepatitis type 1. The study reveals comparable specificity and overall performance metrics, potentially offering laboratories enhanced diagnostic flexibility for this rare but serious liver condition.
German biotechnology company ProBioGen has been selected to design, construct, and operate the GMP manufacturing facility at Berlin’s new Centre for Gene and Cell Therapies, establishing a critical infrastructure node for translating advanced therapeutic research into clinical applications across Europe.
Bioscience will serve as the exclusive UK and Ireland distributor for Bio X Cell’s premium monoclonal antibody portfolio. The strategic partnership aims to enhance researcher access to high-quality functional antibodies across academic and biotech institutions throughout both regions.
Biotech company, Atelerix, specialising in non-cryogenic cell preservation technology appoints industry leaders Sunil Shah and Dr Catherine Elton to drive commercial scale-up and international market penetration across life sciences sectors.
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.